Skip to the page

Data / Form D filings / Companion Spine, LLC

Companion Spine, LLC: Form D filing

Companion Spine, LLC, a pharmaceuticals company in New York, NY, filed a Form D with the SEC in 2024. The latest, on February 14, 2024, reports $8.5 million sold of a $20 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
505 PARK AVE., 14TH FLOOR, New York, NY, 10022
Phone
(212) 583-9700
Industry
Pharmaceuticals
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2002037

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 14, 2024New notice$20,000,000$8,500,000$11,500,0001Nov 2, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Anthony G ViscogliosiExecutive Officer, Director
John G ViscogliosiDirector
Marc R ViscogliosiDirector

Other pharmaceuticals companies in New York that filed recently

Every Form D from the week of Feb 12, 2024 · All recent filings in New York · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Companion Spine, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.